Acoustic perfusion devices
Acoustic perfusion devices and processes for separating biomolecules from other material in a fluid mixture are disclosed. The devices include an inlet port, an outlet port, and a collection port that are connected to an acoustic chamber. An ultrasonic transducer creates an acoustic standing wave in the acoustic chamber that permits a continuous flow of fluid to be recovered through the collection port while keeping the biological cells within the acoustic chamber to be returned to the bioreactor from which the fluid mixture is being drawn.
1. A process for separating biomolecules from a fluid mixture, the process comprising:
flowing a fluid mixture containing biomolecules and cells through an acoustic perfusion device, the acoustic perfusion device comprising:
an acoustic chamber that receives the fluid mixture containing the biomolecules and cells; and
an ultrasonic transducer that includes a piezoelectric material that can be excited to generate a multi-dimensional acoustic standing wave in the acoustic chamber;
exciting the ultrasonic transducer to create the multi-dimensional acoustic standing wave; and
retaining cells with a larger size in the fluid mixture with the multi-dimensional acoustic standing wave.
2. The process of claim 1 , wherein the cells with a larger size are trapped by the multi-dimensional acoustic standing wave and the biomolecules pass through the multi-dimensional acoustic standing wave.
3. The process of claim 2 , wherein the trapped cells are recycled to a bioreactor upstream of the acoustic perfusion device.
4. The process of claim 1 , wherein the biomolecules are therapeutic antibodies.
5. The process of claim 4 , wherein a fucosylation of the therapeutic antibodies is increased and the efficacy of the therapeutic antibodies is changed.
6. The process of claim 1 , wherein the biomolecules are produced by culturing cells in a bioreactor prior to flowing the fluid mixture through the acoustic perfusion device.
7. The process of claim 1 , wherein a pressure rise and an acoustic radiation force on cells are generated at an interface region of the multi-dimensional acoustic standing wave to clarify the fluid mixture as it passes through the multi-dimensional acoustic standing wave.
8. The process of claim 1 , wherein the acoustic perfusion device further comprises a recirculating fluid stream that transports away cells that are held back at the interface region of the multi-dimensional acoustic standing wave.
9. The process of claim 1 , wherein the multi-dimensional acoustic standing wave results in an acoustic radiation force that includes an axial force component and a lateral force component that are of the same order of magnitude.
10. The process of claim 1 , wherein biomolecule aggregates that pass through the multi-dimensional acoustic standing wave are collected outside and downstream of the acoustic perfusion device.
11. The process of claim 1 , wherein biomolecules recovered from the acoustic perfusion device are subjected to further processing downstream of the acoustic perfusion device.
12. The process of claim 11 , wherein the further processing includes at least one of chromatography and additional filtration.
13. The process of claim 12 , wherein the additional filtration includes at least one of depth filtration, crossflow filtration, tangential filtration, and sterile filtration.
14. The process of claim 1 , further comprising glycoengineering the biomolecules to produce antibodies with predetermined glycoforms.
15. A process for collecting biomolecules from a cell culture, the process comprising:
flowing a nutrient fluid stream through the cell culture to collect the biomolecules;
flowing the nutrient fluid stream through an acoustic perfusion device, the acoustic perfusion device including at least one ultrasonic transducer including a piezoelectric material configured to generate a multi-dimensional acoustic standing wave that holds the cell culture in the acoustic perfusion device; and
driving the ultrasonic transducer to generate the multi-dimensional acoustic standing wave and separate any biomolecule aggregates present in the nutrient fluid stream; and
separating the biomolecules from the nutrient fluid stream.
16. The process of claim 15 , wherein the biomolecules are monoclonal antibodies.
17. The process of claim 15 , wherein any cells in the nutrient fluid stream are recycled back to the cell culture.